Public Profile

Sanofi SA

Sanofi SA, a global healthcare leader headquartered in Switzerland (CH), is renowned for its innovative contributions to the pharmaceutical industry. Founded in 2004 through the merger of Sanofi-Synthélabo and Aventis, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Specialising in prescription medicines, vaccines, and consumer healthcare products, Sanofi is committed to addressing complex health challenges. Its core offerings include diabetes care solutions, rare disease treatments, and vaccines, distinguished by their cutting-edge research and development. With a robust market position, Sanofi has achieved notable milestones, such as being a top player in the global vaccine market and consistently ranking among the leading pharmaceutical companies worldwide.

DitchCarbon Score

How does Sanofi SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

63

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Sanofi SA's score of 63 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Sanofi SA's reported carbon emissions

Sanofi SA, headquartered in Switzerland (CH), currently does not provide specific carbon emissions data for the most recent year, as no emissions figures are available. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that Sanofi may still be in the process of establishing or reporting on its climate commitments and emissions reduction strategies. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their carbon footprints, but specific details regarding Sanofi's initiatives remain unclear at this time.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sanofi SA's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sanofi SA is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sanofi SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

2seventy bio, Inc.

US
Health and social work services (85)
Updated 3 days ago

Amgen

US
Chemicals nec
Updated 2 days ago

Genmab

DK
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Janssen

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

MERCK Kommanditgesellschaft auf Aktien

DE
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers